Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja Matic

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 7, 2022
Donor-Derived Cell-Free DNA for the Detection of Heart Allograft Injury: The Impact of the Timing of the Liquid BiopsyJeroen G H P Verhoeven, Dennis A Hesselink, Annemiek M A Peeters, et al.
Clinical Pharmacokinetics|September 16, 2023
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1Mirjam de With, Leni van Doorn, Esmay Kloet, et al.
JCO Precision Oncology|July 21, 2022
<i>DPYD*7</i> as a Predictor of Severe Fluoropyrimidine-Related Adverse EventsMirjam de With, Gemma Brufau, Laila A van den Berg, et al.
European Journal of Human Genetics : EJHG|September 27, 2021
Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)Maja Matic, Marga Nijenhuis, Bianca Soree, et al.
European Journal of Human Genetics : EJHG|July 16, 2021
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)Maja Matic, Marga Nijenhuis, Bianca Soree, et al.
Clinical Pharmacokinetics|June 13, 2023
CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer PatientsRuben A G van Eerden, Nikki S IJzerman, Milan van Meekeren, et al.
Pharmacogenomics|April 2, 2026
The 8th European Society of Pharmacogenomics and Personalized Therapy (ESPT) congressRon H N van Schaik, Jesse J Swen, Adrián Llerena, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 7, 2022
Donor-Derived Cell-Free DNA for the Detection of Heart Allograft Injury: The Impact of the Timing of the Liquid BiopsyJeroen G H P Verhoeven, Dennis A Hesselink, Annemiek M A Peeters, et al.
Clinical Pharmacokinetics|September 16, 2023
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1Mirjam de With, Leni van Doorn, Esmay Kloet, et al.
JCO Precision Oncology|July 21, 2022
<i>DPYD*7</i> as a Predictor of Severe Fluoropyrimidine-Related Adverse EventsMirjam de With, Gemma Brufau, Laila A van den Berg, et al.
European Journal of Human Genetics : EJHG|September 27, 2021
Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)Maja Matic, Marga Nijenhuis, Bianca Soree, et al.
European Journal of Human Genetics : EJHG|July 16, 2021
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)Maja Matic, Marga Nijenhuis, Bianca Soree, et al.
Clinical Pharmacokinetics|June 13, 2023
CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer PatientsRuben A G van Eerden, Nikki S IJzerman, Milan van Meekeren, et al.
Pharmacogenomics|April 2, 2026
The 8th European Society of Pharmacogenomics and Personalized Therapy (ESPT) congressRon H N van Schaik, Jesse J Swen, Adrián Llerena, et al.
Pageof 4